AFLAC INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.26 USD | -0.21% |
|
-3.21% | -2.72% |
| Apr. 15 | Morgan Stanley Raises Price Target on Aflac to $84 From $80, Maintains Equalweight Rating | MT |
| Apr. 11 | Wells Fargo Cuts Price Target on Aflac to $81 From $83, Keeps Equalweight Rating | MT |
Financials (USD)
| Sales 2024 * | 17.17B | Sales 2025 * | 17.5B | Capitalization | 46.18B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.57B | Net income 2025 * | 3.64B | EV / Sales 2024 * | 2.91 x |
| Net Debt 2024 * | 3.74B | Net Debt 2025 * | 3.06B | EV / Sales 2025 * | 2.81 x |
| P/E ratio 2024 * |
12.8
x | P/E ratio 2025 * |
12
x | Employees | 12,785 |
| Yield 2024 * |
2.41% | Yield 2025 * |
2.54% | Free-Float | 38.38% |
More Fundamentals
* Assessed data
More news
Latest transcript on Aflac Incorporated
More recommendations
More press releases
| 1 day | -0.21% | ||
| 1 week | +0.78% | ||
| Current month | -6.52% | ||
| 1 month | -5.01% | ||
| 3 months | -4.01% | ||
| 6 months | -0.11% | ||
| Current year | -2.72% |
1 week
79.31
81.52
1 month
79.3186.26
Current year
75.0886.26
1 year
64.1086.26
3 years
51.2886.26
5 years
23.0786.26
10 years
23.0786.26
| Managers | Title | Age | Since |
|---|---|---|---|
Dan Amos
CEO | Chief Executive Officer | 72 | 72-12-31 |
Max Brodén
DFI | Director of Finance/CFO | 45 | 17-04-02 |
Thomas McDaniel
CMP | Compliance Officer | - | 03-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dan Amos
CEO | Chief Executive Officer | 72 | 72-12-31 |
Barbara Rimer
BRD | Director/Board Member | 75 | 94-12-31 |
William Bowers
BRD | Director/Board Member | 67 | 12-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.14% | 204 M€ | +10.54% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 80.26 | -0.21% | 1,961,109 |
| 24-04-16 | 80.43 | +0.20% | 2,114,324 |
| 24-04-15 | 80.27 | -0.01% | 2,437,394 |
| 24-04-12 | 80.28 | +0.80% | 2,882,756 |
| 24-04-11 | 79.64 | -3.96% | 3,399,048 |
Delayed Quote Nyse, April 17, 2024 at 04:00 pm EDT
More quotes
Aflac Incorporated is a life insurance group organized around 3 sectors of activity:
- sale of health and life insurance products in Japan (57.7% of net sales): including cancer life plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities;
- sale of health and life insurance products in the United States (39.5%): including accident/disability plans, cancer expense plans, short-term disability plans, sickness and hospital indemnity plans, hospital intensive care plans, fixed-benefit dental plans, vision care plans, and long-term care plans;
- other (2.8%).
Sector
Life & Health Insurance
Calendar
2024-04-30
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
80.43
USD
Average target price
84.54
USD
Spread / Average Target
+5.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.72% | 46.28B | |
| +13.46% | 77.68B | |
| +4.22% | 49.84B | |
| +7.38% | 41B | |
| +3.51% | 38.67B | |
| +17.61% | 37.67B | |
| +0.64% | 29.3B | |
| -8.64% | 27.22B | |
| -21.98% | 23.42B | |
| +4.70% | 21.57B |
- Stock Market
- Equities
- AFL Stock
